register

Medical and Science

Private oncologists welcome subsidised telehealth for vulnerable patients

Health Industry Hub | March 18, 2020 |

The nation’s peak body of cancer doctors has applauded the Morrison Government for its swift and unprecedented move to offer bulkbilled telehealth appointments for certain groups of vulnerable Australians.

The Private Cancer Physicians of Australia (PCPA) said the pace in which the Government has moved to apply Medicare Benefits Schedule (MBS) items to telehealth GP and specialist appointments for patients, most at risk of the COVID-19 virus (or those self-isolating), was unprecedented.

“Like any patient with an underlying chronic health issues, cancer patients are particularly vulnerable during this pandemic,” said the President of the PCPA, Dr Christopher Steer. 

“Our patients are regular attendees at their GP clinics and out-patient clinics, which are now being frequented with those who have the COVID-19 virus.

“If cancer patients, many of whom will have a compromised immunity, can be provided with medical advice and support, over the phone or via a videoconference, rather than sitting in a doctors’ waiting room, then that is a significantly safer option for them,” Dr Steer said.

Register FREE and join 20,000+ industry professionals who receive the latest industry news, innovations and insights from Health Industry Hub; the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.

The measure MBS Telehealth, was announced by the Morrison Government last week.

This is a temporary six-month measure. Should the Australian Health Protection Principal Committee (AHPPC) recommend an extension, it will be considered by the Government.

“Being diagnosed with cancer and having treatment is stressful as it is,” said Dr Steer. “Knowing you can now access a bulk billed appointment with your doctor, from the safety of your own home, is a very welcomed development and one we hope may continue past this pandemic.”

HCP engagement in COVID-19 times – Keep your people safe and maximise HCP reach and engagement digitally. Learn more about how we can help your team – solutions developed by industry for industry.


Leadership & Management

New study challenges trend-driven leadership frameworks

New study challenges trend-driven leadership frameworks

Health Industry Hub | January 22, 2025 |

The secret to effective leadership may lie in its simplicity. New research highlights the importance of strong leader-follower relationships over […]

More


News & Trends - Pharmaceuticals

Complex policy problem: How to tackle Australia's persistent medicine shortages

Complex policy problem: How to tackle Australia’s persistent medicine shortages

Health Industry Hub | January 22, 2025 |

The debate over medicine shortages has erupted again, as the Australian Medical Association (AMA) and the Pharmacy Guild of Australia […]

More


News & Trends - MedTech & Diagnostics

Overhaul of funding for CIED technical services expected to take up to 18 months

Overhaul of funding for CIED technical services expected to take up to 18 months

Health Industry Hub | January 22, 2025 |

The Department of Health (DoH) has unveiled stakeholder views regarding the current approach to cardiac implantable electronic devices (CIED) and […]

More


Medical and Science

Demand surges for scientist role in policy-making amid calls for more transparency

Demand surges for scientist role in policy-making amid calls for more transparency

Health Industry Hub | January 22, 2025 |

Two-thirds of Australians believe scientists should actively advocate for specific policies, with over 60% urging greater scientist involvement in policy-making. […]

More


This content is copyright protected. Please subscribe to gain access.